FrancophonIA/ELRC3.0 huggingface dataset:
English: Rhabdomyolysis: an increase in CPK, myalgia, myositis, and rarely, rhabdomyolysis, have been reported with protease inhibitors, more specifically in association with nucleoside analogues.
Estonian: Rabdomüolüüs: proteaasi inhibiitorite, täpsemalt nukleosiidi analoogide kasutamisel on kirjeldatud kreatiinfosfokinaasi aktiivsuse suurenemist, müalgiat, müosiiti ja harva rabdomüolüüsi.
English: Lovastatin: ↑ expected Simvastatin: ↑ expected (CYP3A4 inhibition by FPV/RTV)
Estonian: Lovastatiin: oodatav  Simvastatiin: oodatav  (CYP3A4 inhibeerimine FPV/RTV poolt)
English: Lidocaine: ↑ expected (CYP3A4 inhibition by FPV/RTV)
Estonian: Lidokaiin: oodatav  (CYP3A4 inhibeerimine FPV/RTV poolt)
English: A dosing syringe with a 10 ml graduation is supplied with the pack so you can measure your dose accurately.
Estonian: Annuse täpseks mõõtmiseks on pakendis kaasas 10 ml skaalajaotusega annustamissüstal.
English: Telzir tablets may be taken without regard to food intake.
Estonian: Telzir'i tablette võib manustada söögiaegadest sõltumatult.
English: България
Estonian: Iirimaa
English: CYP3A are co-administered nilotinib with ibrutinib vinblastine everolimus
Estonian: CYP3A VAHENDUSEL METABOLISEERUVAD KASVAJATEVASTASED RAVIMID Sellised kasvajatevastased ravimid on näiteks: dasatiniib nilotiniib ibrutiniib vinblastiin everoliimus
English: ANTICONVULSANTS Phenytoin
Estonian: Astemisool Terfenadiin
English: Halofantrine: ↑ expected (CYP3A4 inhibition by FPV/RTV)
Estonian: Halofantriin: oodatav  (CYP3A4 inhibeerimine FPV/RTV poolt)
English: Abacavir
Estonian: Kehakaal
English: Flecainide: ↑ expected
Estonian: Itrakonasool: oodatav 
English: Lopinavir / ritonavir
Estonian: Lööve/nahareaktsioonid
English: Susceptiple to FPV/RTV
Estonian: FPV/RTV BID
English: Placental transfer of amprenavir has been shown to occur in humans.
Estonian: On näidatud, et inimestel läbib amprenaviir platsentat.
English: ORAL ANTICOAGULANTS
Estonian: ANTIKONVULSANDID Fenütoiin
English: telzir 700 mg
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) telzir 700 mg
English: Zidovudine
Estonian: Daklatasviir
English: Mean (n)
Estonian: (n)
English: Don't push too hard and squirt the liquid into the back of the throat or you may choke.
Estonian: Jõuline pritsimine vastu neelu tagaseina võib põhjustada läkastamist.
English: Fluticasone propionate: ↑ Intrinsic cortisol levels: ↓
Estonian: Organismi kortisooli tase: 
English: Cisapride: ↑ expected (CYP3A4 inhibition by FPV/RTV)
Estonian: Tsisapriid: oodatav  (CYP3A4 inhibeerimine FPV/RTV poolt)
English: Blood cholesterol increased Blood triglycerides increased Alanine aminotransferase increased
Estonian: Vere triglütseriidide sisalduse suurenemine
English: • lidocaine given by injection
Estonian: • süstitav lidokaiin
English: Amprenavir ↓ expected (CYP3A4 induction by St. John's wort)
Estonian: Amprenaviir: oodatav  (CYP3A4 indutseerimine naistepuna poolt)
English: Rash / cutaneous reactions
Estonian: Lööve / nahareaktsioonid
English: These medicines are not recommended with Telzir/ritonavir: - doses of ketoconazole and itraconazole greater than 200 mg per day (used to treat fungal infections) - doses of rifabutin greater than 150 mg every other day (an antibiotic) - lidocaine given by injection - halofantrine (used to treat malaria) - sildenafil, vardenafil or tadalafil (used to treat erectile dysfunction) - doses of atorvastatin greater than 20 mg per day (used to lower cholesterol) - fluticasone propionate and similar medicines used to treat asthma, unless considered essential.
Estonian: - pimosiid (kasutatakse skisofreenia raviks) - kvetiapiin (kasutatakse skisofreenia, bipolaarse häire ja depressiooni raviks) - lurasidoon (kasutatakse skisofreenia ja bipolaarse häire raviks) - tsisapriid (kasutatakse seedehäirete raviks) - ergotamiini derivaadid (kasutatakse peavalu raviks) - rifampitsiin (kasutatakse tuberkuloosi raviks) - amiodaroon, kinidiin, flekainiid ja propafenoon (südameravimid) - bepridiil (kasutatakse kõrgvererõhu raviks) - suukaudne midasolaam või suukaudne triasolaam (kasutatakse ärevuse raviks) - naistepunaürti (Hypericum perforatum) sisaldavad preparaadid - lovastatiin, simvastatiin (kasutatakse kolesterooli alandamiseks) - sildenafiil, kui seda kasutatakse pulmonaalse arteriaalse hüpertensiooni (kopsuveresoonte haiguse) raviks - paritapreviir (kasutatakse C-hepatiidi viirusinfektsiooni raviks).
English: 90 x 1 tablets (unit dose)
Estonian: 90 x 1 tabletti (üksikannus)
English: 32.27 g
Estonian: Pulber: 32,27 g
English: Solution for injection Intravenous use vial (glass)
Estonian: Intravenoosne Viaal (klaas
English: Powder for oral suspension bottle (glass)
Estonian: Pudel (klaas)
English: l t o r
Estonian: Pakendi suurus l n a
English: Package size
Estonian: Manustamistee Pakendi iseloomustus
English: The European Commission granted a marketing authorisation valid throughout the European Union for Adasuve on 20 February 2013.
Estonian: Euroopa Komisjon andis Adasuve müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 20. veebruaril 2013.
English: This summary was last updated in 2-2013.
Estonian: Kokkuvõtte viimane uuendus: 2-2013.
English: Regarding its safety, most side effects are comparable to those of other antipsychotic medicines.
Estonian: Ohutuse osas on enamik kõrvalnähtudest võrreldavad teiste antipsühhootiliste ravimite omadega.
English: Adasuve loxapine
Estonian: Adasuve loksapiin
English: The full EPAR for Adasuve can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Adasuve kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Its action on receptors for other neurotransmitters may also play a role.
Estonian: Ravimi toime retseptoritele teiste neurotransmitterite suhtes võib samuti olla tähtis.
English: A fall in PEC score indicates an improvement in symptoms.
Estonian: PEC-skoori vähenemine näitab sümptomite paranemist.
English: Adasuve has been studied in two main studies.
Estonian: Adasuvet uuriti kahes põhiuuringus.
English: What measures are being taken to ensure the safe use of Adasuve?
Estonian: Mis meetmed võetakse, et tagada Adasuve kasutamise ohutus?
English: Adasuve should only be used in a hospital under the supervision of a healthcare professional.
Estonian: Adasuvet tohib kasutada ainult haiglas tervishoiutöötaja järelevalve all.
English: Agitation is a known complication of both mental illnesses.
Estonian: Erutus on mõlema vaimuhaiguse teadaolev tüsistus.
English: Other information about Adasuve
Estonian: Muu teave Adasuve kohta
English: The PEC score at the beginning of the study for these groups of patients was between 17 and 18.
Estonian: Uuringu alguses oli PEC-skoor nendes patsiendirühmades 17-18 punkti.
English: The company that makes Adasuve must ensure that all healthcare professionals who are expected to use Adasuve receive an information pack containing key information on how to use the medicine as well as important safety information.
Estonian: Adasuvet tootev ettevõte peab tagama, et kõik tervishoiutöötajad, kes eeldatavasti kasutavad Adasuvet, saavad teabepaketi, mis sisaldab ravimi kasutamise ja ohutuse põhiteavet.
English: One study involved 344 patients with schizophrenia and the second study involved 314 patients with bipolar disorder.
Estonian: Ühes uuringus osales 344 skisofreeniaga patsienti ja teises 314 bipolaarse häirega patsienti.
English: If considered necessary the doctor may prescribe a second dose of 9.1 mg after two hours.
Estonian: Vajaduse korral võib arst määrata teise 9,1 mg Adasuve annuse kahe tunni pärast.
English: The CHMP noted that the administration of Adasuve is non-invasive.
Estonian: Inimravimite komitee märkis, et Adasuve manustamine ei ole invasiivne.
English: Loxapine works mainly by blocking receptors for the neurotransmitters 5-hydroxytryptamine (also called serotonin) and dopamine.
Estonian: Loksapiin blokeerib põhiliselt retseptorid neurotransmitterite 5-hüdroksütrüptamiini (serotoniin) ja dopamiini suhtes.
English: The potential risk of bronchospasm is considered manageable and has been adequately addressed through risk minimisation measures.
Estonian: Bronhospasmi võimalikku riski peetakse reguleeritavaks ja riski vähendamiseks on võetud piisavalt meetmeid.
English: Schizophrenia is a mental illness that has a number of symptoms, including disorganised thinking and speech, hallucinations (hearing or seeing things that are not there), suspiciousness and delusions (mistaken beliefs).
Estonian: Skisofreenia on vaimuhaigus, millel on mitmeid sümptomeid, sealhulgas kaootiline mõtlemine ja kõne, hallutsinatsioonid (ebareaalsete asjade kuulmine või nägemine), kahtlustamine ja luulud.
English: This is a summary of the European public assessment report (EPAR) for Adasuve.
Estonian: See on ravimi Adasuve Euroopa avaliku hindamisaruande kokkuvõte.
English: It must also not be used in patients with symptoms such as wheezing and shortness of breath or who have lung conditions such as asthma or chronic obstructive pulmonary disease.
Estonian: Samuti ei tohi seda kasutada patsiendid, kellel esineb vilistav ja raskendatud hingamine või kellel on kopsuhaigus, näiteks astma või krooniline obstruktiivne kopsuhaigus.
English: Information on how to use the inhaler can be found in the package leaflet.
Estonian: Inhalaatori kasutamise teave on pakendi infolehel.
English: Since these neurotransmitters are involved in agitation in schizophrenia and bipolar disorder, loxapine helps to normalise the activity of the brain, reducing agitation.
Estonian: Et need neurotransmitterid on skisofreenia ja bipolaarse häire puhul seotud agiteeritusega, aitab loksapiin agiteeritust vähendades aju aktiivsust normaliseerida.
English: The CHMP concluded that the benefits of Adasuve outweigh its risks and recommended that it be granted marketing authorisation.
Estonian: Inimravimite komitee otsustas, et Adasuve kasulikkus on suurem kui sellega kaasnevad riskid, ja soovitas anda ravimi müügiloa.
English: The main measure of effectiveness was the change in the patients' symptoms two hours after giving a dose of loxapine, assessed using a standard scale of agitation in patients with schizophrenia and bipolar disorder (positive and negative symptom scale, excited component: PEC score).
Estonian: Efektiivsuse põhinäitaja oli muutus patsientide sümptomites kaks tundi pärast loksapiini annuse saamist, mida hinnati skisofreenia ja bipolaarse häirega patsientidel agiteerituse standardskaala alusel (positiivsete ja negatiivsete sümptomite skaala, agiteerituse komponent: PEC-skoor).
English: For more information about treatment with Adasuve, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Adasuvega toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: It is available as an inhalation powder in a portable inhaler device for single use (4.5 mg and 9.1 mg).
Estonian: Seda turustatakse inhalatsioonipulbrina üheannuselises inhalaatoris (4,5 mg ja 9,1 mg).
English: Bipolar disorder is a mental illness with alternating periods of high mood and depression.
Estonian: Bipolaarne häire on vaimuhaigus, mille korral vahelduvad kõrgendatud meeleolu ja depressioon.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Adasuve.
Estonian: Selles selgitatakse, kuidas inimravimite komitee hindas ravimit ja otsustas toetada müügiloa andmist; samuti esitatakse komitee soovitused, kuidas ravimit kasutada.
English: What is Adasuve?
Estonian: Mis on Adasuve?
English: In studies in agitated patients, bronchospasm was reported as an uncommon but serious adverse reaction, while in subjects with active airways disease, bronchospasm was commonly reported and often required treatment with a short acting beta-agonist.
Estonian: Agiteeritud patsientide uuringutes teatati bronhospasmist kui aeg-ajalt esinevas raskest kõrvalnähust, samas kui aktiivse hingamisteede haigusega osalejatel teatati bronhospasmist sageli ja see vajas ka ravi lühitoimelise beetaagonistiga.
English: Both studies compared 4.5 mg and 9.1 mg of Adasuve with placebo (a dummy treatment).
Estonian: Mõlemas uuringus võrreldi Adasuve 4,5 mg ja 9,1 mg annuseid platseeboga (näiv ravim).
English: Why has Adasuve been approved?
Estonian: Miks Adasuve heaks kiideti?
English: Patients should be observed for signs of shortness of breath for one hour after each dose.
Estonian: Pärast iga annust tuleb patsienti ühe tunni jooksul jälgida hingeldusnähtude suhtes.
English: Adasuve is used to rapidly control mild to moderate agitation in adults with schizophrenia or bipolar disorder.
Estonian: Adasuvet kasutatakse kerge kuni mõõduka erutuse kiireks kontrolli alla saamiseks skisofreenia või bipolaarse häirega täiskasvanutel.
English: The most common side effects with Adasuve are dysgeusia (taste disturbances), sedation or somnolence (sleepiness) and dizziness.
Estonian: Adasuve kõige sagedamad kõrvalnähud on düsgeusia (maitsehäired), sedatsioon ja unisus ning peapööritus.
English: In the study in patients with schizophrenia, patients taking 4.5 mg of Adasuve had an average fall in PEC score of 8.0 points and patients taking 9.1 mg had an average fall of 8.7 points.
Estonian: Skisofreeniaga patsientide uuringus vähenes 4,5 mg Adasuvet saanud patsientidel keskmine PEC-skoor 8,0 punkti ja 9,1 mg saanud patsientidel 8,7 punkti.
English: In the brain, it attaches to and blocks several different receptors on the surface of nerve cells.
Estonian: Ajus kinnitub see närviraku pinna eri retseptoritele ja blokeerib need.
English: What is the risk associated with Adasuve?
Estonian: Mis riskid Adasuvega kaasnevad?
English: Adasuve was more effective than placebo at controlling agitation.
Estonian: Adasuve oli agiteerituse reguleerimisel platseebost efektiivsem.
English: The active substance in Adasuve, loxapine, is an antipsychotic medicine.
Estonian: Adasuve toimeaine loksapiin on antipsühhootiline ravim.
English: Treatment with Adasuve is started with the inhalation of a single dose of 9.1 mg.
Estonian: Ravi Adasuvega alustatakse 9,1 mg üksikannuse inhaleerimisest.
English: For the full list of all side effects reported with Adasuve, see the package leaflet.
Estonian: Adasuve kohta teatatud kõrvalnähtude täielik loetelu on pakendi infolehel.
English: Adasuve is a medicine that contains the active substance loxapine.
Estonian: Adasuve on ravim, mis sisaldab toimeainena loksapiini.
English: Adasuve must not be used in people who are hypersensitive (allergic) to loxapine or any of the other ingredients.
Estonian: Adasuvet ei tohi kasutada patsiendid, kes võivad olla loksapiini või selle ravimi mis tahes muu koostisaine suhtes ülitundlikud (allergilised).
English: In the study in patients with bipolar disorder, patients taking 4.5 mg of Adasuve had an average fall in PEC score of 8.2 points, and patients taking 9.1 mg had an average fall of 9.2 points.
Estonian: Bipolaarse häirega patsientide uuringus vähenes 4,5 mg Adasuvet saanud patsientidel keskmine PECskoor 8,2 punkti ja 9,1 mg saanud patsientidel 9,2 punkti.
English: What benefit has Adasuve shown during the studies?
Estonian: Milles seisneb uuringute põhjal Adasuve kasulikkus?
English: The CHMP concluded that Adasuve has been demonstrated to rapidly control (within minutes) mild to moderate agitation in patients with schizophrenia or bipolar disorder who are cooperative with using an inhaler.
Estonian: Inimravimite komitee järeldas, et Adasuve kohta on tõendatud kerge kuni mõõduka agiteerituse kiire (mõneminutiline) reguleerimine skisofreenia või bipolaarse häirega patsientidel, kes on inhalaatorit kasutamisel koostöövalmid.
English: A lower dose of 4.5 mg may be prescribed if the patient did not tolerate the initial dose of 9.1 mg or if a lower dose is considered more appropriate.
Estonian: Kui patsient ei talunud 9,1 mg algannust või kui väiksemat annust peetakse sobivamaks, võib määrata 4,5 mg annuse.
English: How is Adasuve used?
Estonian: Kuidas Adasuvet kasutatakse?
English: How has Adasuve been studied?
Estonian: Kuidas Adasuvet uuriti?
English: The effects of Adasuve were first tested in experimental models before being studied in humans.
Estonian: Enne inimuuringuid kontrolliti Adasuve toimet muude katsetega.
English: What is Adasuve used for?
Estonian: Milleks Adasuvet kasutatakse?
English: An airway-opening medicine called a short-acting beta agonist should also be available for the treatment of patients who develop bronchospasm (excessive and prolonged contraction of the airway muscles).
Estonian: Käepärast peab olema hingamisteid laiendav lühitoimeline beetaagonist patsientide jaoks, kellel tekib bronhospasm (bronhiseinte lihaste pikaajaline kramp).
English: This compared with a fall of 5.8 points in patients taking placebo.
Estonian: Platseebot saanud patsientidel esines 5,8-punktine vähenemine.
English: The medicine can only be obtained with a prescription.
Estonian: Adasuve on retseptiravim.
English: This compared with a fall of 4.7 points in patients taking placebo.
Estonian: Platseebot saanud patsientidel esines 4,7punktine vähenemine.
English: How does Adasuve work?
Estonian: Kuidas Adasuve toimib?
English: This disrupts signals transmitted between brain cells by ‘neurotransmitters', chemicals that allow nerve cells to communicate with each other.
Estonian: See häirib neurotransmitterite vahendatavaid signaale.
English: Conditions or restrictions with regard to the safe and effective use of the medicinal product
Estonian: Tingimused või piirangud, mis puudutavad ravimi ohutut ja tõhusat kasutamist
English: The MAH shall provide an educational pack targeting all physicians who are expected to prescribe/use Pioglitazone.
Estonian: Müügiloa hoidja peab tagama infomaterjalid kõigile arstidele, kes eeldatavasti hakkavad Pioglotazone Actavis't välja kirjutama/kasutama.
English: • The risk of bladder cancer risk and relevant risk minimisation advice.
Estonian: - viiteid põievähi riskile ning asjakohaseid riski minimeerimise juhiseid.
English: • Your doctor will regularly monitor your condition to check that the treatment is having the desired effect.
Estonian: • Arst jälgib regulaarselt teie seisundit kontrollimaks, kas ravi avaldab soovitud toimet.
English: The expiry date refers to the last day of that month.
Estonian: Kõlblikkusaeg viitab selle kuu kuu viimasele päevale.
English: 112 tablets.
Estonian: 112 tabletti.
English: Your doctor will tell you exactly how many tablets of Jalra to take.
Estonian: Arst ütleb teile täpselt, kui palju Jalra tablette võtta.
English: Medical attention may be needed.
Estonian: Vajalikuks võib osutuda arstiabi.
English: These changes are, however, not considered to be clinically relevant.
Estonian: Neid muutusi ei loeta kliiniliselt olulisteks.
English: Then take your next dose at the usual time.
Estonian: Järgmine annus võtke tavalisel ajal.
English: • if you have or have had a disease of the pancreas.
Estonian: • kui teil on või on olnud kõhunäärme haigus.
English: How much to take and when
Estonian: Kui palju ja millal ravimit võtta
English: • Take Jalra every day for as long as your doctor tells you.
Estonian: • Võtke Jalra't iga päev senikaua, kui arst on määranud.
English: The maximum daily dose is 100 mg.
Estonian: Maksimaalne päevane annus on 100 mg.
English: No data are available (see also section 5.1).
Estonian: Andmed puuduvad (vt ka lõik 5.1).
English: You may have to take this treatment over a long period of time.
Estonian: See ravi võib olla pikaajaline.
English: Date of first authorisation: 19 November 2008 Date of latest renewal: 28 November 2013
Estonian: Müügiloa esmase väljastamise kuupäev: 19. november 2008 Müügiloa viimase uuendamise kuupäev: 23. juuli 2012
English: Adjudicated cardiovascular events were balanced overall.
Estonian: Hinnatud kardiovaskulaarsed toimed olid üldiselt tasakaalustatud.
English: If you have questions about how long to take this medicine, talk to your doctor.
Estonian: Kui teil on küsimusi selle kohta, kui kaua seda ravimit võtta, pidage nõu oma arstiga.
English: Statistical non-inferiority was not achieved.
Estonian: Statistilist samaväärsust ei saavutatud.
English: If you take too many Jalra tablets, or if someone else has taken your medicine, talk to your doctor straight away.
Estonian: Kui te võtate liiga palju Jalra tablette või keegi teine on võtnud teie ravimit, pöörduge otsekohe oma arsti poole.
English: (type A) and magnesium stearate.
Estonian: A) ja magneesiumstearaat.
English: However, the magnitude of change is not clinically significant, so that Jalra can be given with or without food.
Estonian: Kuid muutus ei olnud kliiniliselt oluline, mistõttu Jalra't võib manustada koos toiduga või ilma.
English: The maximum change (increase or decrease) in the exposure to vildagliptin is ~30%, which is not considered to be clinically relevant.
Estonian: Vildagliptiini ekspositsiooni maksimaalne muutus (suurenemine või vähenemine) on 30%, mida ei loeta kliiniliselt oluliseks.
English: Other medicines and Jalra
Estonian: Muud ravimid ja Jalra
English: Pharmacotherapeutic group: Drugs used in diabetes, dipeptidyl peptidase 4 (DPP-4) inhibitors, ATC code: A10BH02
Estonian: Farmakoterapeutiline rühm: Diabeediravimid, dipeptidüülpeptidaas 4 (DPP-4) inhibiitorid, ATC-kood: A10BH02
English: One side is debossed with “NVR”, and the other side with “FB”.
Estonian: Ühel küljel on kiri „NVR” ja teisel „FB”.
English: EU/1/08/485/011 336 tablets (3 packs of 112)
Estonian: EU/1/08/485/011 336 tablets (3 karpi, mis sisaldavad 112)
English: In the event of an overdose, supportive management is recommended.
Estonian: Üledoosi korral on soovitatav toetav ravi.
English: How to take Jalra • Swallow the tablets whole with some water.
Estonian: Kuidas Jalra't võtta • Neelake tabletid tervelt koos veega.
English: Rare cases of hepatic dysfunction (including hepatitis) have been reported.
Estonian: Harvadel juhtudel on teatatud maksa väärtalitlusest (kaasa arvatud hepatiit).
English: • if you have type 1 diabetes (i.e. your body does not produce insulin) or if you have a condition called diabetic ketoacidosis.
Estonian: • kui teil on I tüüpi suhkurtõbi (st, et teie organism ei tooda insuliini) või teil on seisund, mida kutsutakse diabeetiliseks ketoatsidoosiks.
English: If you have previously taken vildagliptin but had to stop taking it because of liver disease, you should not take this medicine.
Estonian: Kui te olete varem võtnud vildagliptiini, aga olete pidanud võtmise lõpetama maksahaiguse tõttu, ei soovitata seda ravimit võtta.
English: Doses higher than 100 mg are not recommended.
Estonian: Üle 100 mg annuste kasutamine ei ole soovitatav.
English: Frequencies are defined as very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000), not known (cannot be estimated from the available data).
Estonian: Esinemissagedus on määratletud kui väga sage (≥1/10), sage (≥1/100 kuni <1/10), aeg-ajalt (≥1/1000 kuni <1/100), harv (≥1/10000 kuni <1/1000), väga harv (<1/10000), teadmata (ei saa hinnata olemasolevate andmete alusel).
English: Multipack: 336 (3 packs of 112) tablets.
Estonian: Mitmikpakend: 336 (3 karpi, mis sisaldavad 112) tabletti.
English: Your doctor will prescribe Jalra either alone or together with certain other antidiabetic medicines which you will already be taking, if these have not proved sufficiently effective to control diabetes.
Estonian: Arst määrab Jalra't kas üksi või koos mõne teise diabeediravimiga, mida te juba võtate, kui need ei ole osutunud piisavalt efektiivseks veresuhkru kontrolli all hoidmiseks.
English: Diabetic skin lesions are a common complication of diabetes.
Estonian: Diabeetilised nahakahjustused on diabeedi sagedased komplikatsioonid.
English: Therefore Jalra should be used with caution in these patients (see also sections 4.2, 5.1 and 5.2).
Estonian: Seetõttu tuleb Jalra't nendel patsientidel kasutada ettevaatusega (vt ka lõigud 4.2, 5.1 ja 5.2).